Does Amarin Need the FDA to Play NCE?

By Brandy Betz Amarin (Nasdaq: AMRN  ) received Food and Drug Administration approval in July for Vascepa, its first drug to market. The treatment for severely high triglyceride ...

Amarin Still Playing the Dating Game

By Keith Speights Probably the best line in the 2000 movie Miss Congenialitywas when Miss Rhode Island was asked to describe her idea of the perfect date. Her response: “April ...

Bristol-Myers, Chiromics form drug discovery strategic alliance

Chiromics LLC announced a strategic research alliance with Bristol-Myers Squibb Company which includes grants of non-exclusive license for use of Chiromics’ chemical compound library, ...

FDA reviewing Merck’s experimental insomnia drug

By The Associated Press WHITEHOUSE STATION, N.J. (AP) — Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its experimental insomnia medication, suvorexant ...

Novo Aims for Tresiba U.S. Approval in First Half of 2013

By Albertina Torsoli Novo Nordisk A/S (NOVOB) is targeting U.S. approval of its experimental diabetes medicine Tresiba in the first half of next year after obtaining the backing ...

CytRx Reports Third Quarter 2012 Financial Results

Reports positive meeting with the FDA to discuss a Phase 3 pivotal trial with aldoxorubicin for patients with advanced soft tissue sarcomas Company is planning to submit a special protocol ...

PropThink: Esbriet Sales Demonstrating Growth; Expansion into New Markets Continues

By Jake King Esbriet (perfenidone) sales in Europe have begun to pick up according to InterMune`s (ITMN) third quarter results, driven largely (91%) by sales in Germany where the drug ...

2 Speculative Biotech Plays That Have Potential

By Matt Schilling Have you ever walked up to a roulette table in a casino and noticed that the two primary colors are red and black? Those colors carry some very nice odds at 2 to ...

CVS shucking more drugs from its coverage list

AndroGel, Lumigan, Onglyza added to CVS no-coverage list By Eric Palmer Beginning in January, the list of drugs CVS Caremark’s ($CVS) pharmacy-benefit business will refuse to ...

Teva’s seasonal allergy drug found effective in children

(Reuters) – Teva Pharmaceuticals Industries Ltd said its seasonal allergic rhinitis drug, already approved to treat adults, significantly improved the nasal condition of children ...

The January Effect And 3 Biopharma Stocks

By EnhydrisPECorp The “January effect” is a market anomaly whereby stock prices tend to decrease year-end followed by a subsequent increase in the month of January. This ...
Page 70 of 70« First...102030...6667686970
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS